Nasal submucosal administration of antigen-presenting cells induces effective immunological responses in cancer immunotherapy

Advances in Oto-Rhino-Laryngology

Volumn 72, Issue , 2011, Pages 149-152

  Okamoto, Yoshitaka ^a   Fujikawa, Akira ^a   Kurosaki, Motoyoshi ^a   Yamasaki, Kazuki ^a   Sakurai, Daijyu ^a   Horiguchi, Shigetoshi ^a   Nakayama, Toshinori ^b  

^a CHIBA UNIVERSITY HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LYMPHOCYTE ANTIGEN RECEPTOR; VALPHA24 PROTEIN, HUMAN;

ANTIGEN PRESENTING CELL; CANCER STAGING; CLINICAL TRIAL; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG PULSE THERAPY; FOLLOW UP; HEAD AND NECK TUMOR; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; INTRANASAL DRUG ADMINISTRATION; METHODOLOGY; MUCOSAL IMMUNITY; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; ANTIGEN-PRESENTING CELLS; CARCINOMA, SQUAMOUS CELL; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNITY, MUCOSAL; IMMUNOTHERAPY; NEOPLASM STAGING; PULSE THERAPY, DRUG; RECEPTORS, ANTIGEN, T-CELL; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 80052464301     PISSN: 00653071     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000324775     Document Type: Conference Paper

References (8)

1. Schuler G, Schuler-Thurner B, Steinman RM: The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 2003;15:138-147. (Pubitemid 36287518)
2. Taniguchi M, Harada M, Kojo S, Nakayama T, Wakao H: The regulatory role of Valpha14 NKT cells in innate and acquired immune response. Annu Rev Immunol 2003;21:483-513. (Pubitemid 37174539)
3. Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M: CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science 1997;278:1626-1629. (Pubitemid 27516282)
4. Horiguchi S, Matsuoka T, Okamoto Y, Sakurai D, Kobayashi K, Chazono H, Hanazawa T, Tanaka Y: Migration of tumor antigen-pulsed dendritic cells after mucosal administration in the human upper respiratory tract. J Clin Immunol 2007;27:598-604.
5. Kobayashi K, Tanaka Y, Horiguchi S, Yamamoto S, Nakayma T, Sugimoto A, Okamoto Y: The effect of radiotherapy on NKT cells in patients with advanced head and neck cancer. Cancer Immunol Immunother 2010;59: 1503-1509.
6. Kurosaki M, Horiguchi S, Yamasaki K, Kunii N, Nakayama T, Okamoto Y: Migration and immunological reaction after administration of aGalCer-pulsed antigen presenting cells into different sites of patients with head and neck cancer. Cancer Immunol Immunother 2011;60:207-215.
7. Uchida T, Horiguchi S, Tanaka Y, Yamamoto H, Kunii N, Motohashi S, Taniguchi M, Nakayama T, Okamoto Y: Phase I study of alpha- galactosylceramidepulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer. Cancer Immunol Immunother 2008;57:337-345. (Pubitemid 350295376)
8. Kunii N, Horiguchi S, Motohashi S, Yamamoto H, Ueno N, Yamamoto S, Sakurai D, Taniguchi M, Nakayama T, Okamoto Y: Combination therapy of in vitro-expanded natural killer T cells and alpha-galactosylceramide-pulsed antigen-presenting cells in patients with recurrent head and neck carcinoma. Cancer Sci 2009;100:1092-1098.